FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/11/2022 |
3. Issuer Name and Ticker or Trading Symbol
Charge Enterprises, Inc. [ CRGE ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 29,737,600 | D | |
Common Stock | 500,000 | I | By son |
Common Stock | 500,000 | I | By daughter |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Options, right to buy | (1) | (1) | Common Stock | 9,750,000 | $0.485 | D | |
Warrants | (2) | (2) | Common Stock | 220,000 | $0.5 | D |
Explanation of Responses: |
1. On October 12, 2020, the Reporting Person was granted options to purchase 9,750,000 shares of common stock pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan. As of the grant date, the vesting of options to purchase 2,437,000 shares occurred, with the remaining options vesting in equal installments as of the anniversary of grant date. The options are exercisable for a term of five years. |
2. Between May 8, 2020 and September 30, 2020, the Issuer entered into securities purchase agreements with investors pursuant to which the Issuer issued convertible notes (the "Subordinated Creditor Notes") and warrants to purchase shares of Common Stock ("Subordinated Creditor Warrants"). On September 2, 2020, the Reporting Person, purchased a Subordinated Creditor Note with an aggregate principal amount of $110,000 and a Subordinated Creditor Warrant to purchase 220,000 shares of common stock for an aggregate purchase price of $100,000. |
/s/ Andrew Scott Fox | 04/11/2022 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |